Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ovarian Neoplasms × Neoadjuvant Therapy × Clear all

Phase

Phase 2 6 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Rectal Neoplasms 9 Colorectal Neoplasms 7 Stomach Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Neoplasm Metastasis 4 Nasopharyngeal Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Adenocarcinoma Of Esophagus 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Neuroblastoma 3 Lung Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Inflammatory Breast Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Adenocarcinoma 2 Wilms Tumor 1 Uveal Melanoma 1 Stage III and IV Ovarian Cancer 1 Sarcoma 1

Interventions

Paclitaxel 64 Carboplatin 52 Bevacizumab 28 liposomal doxorubicin 23 Topotecan 20 Gemcitabine 17 olaparib 15 Cisplatin 13 Doxorubicin 12 Taxes 10 Drug Therapy 10 niraparib 9 Docetaxel 6 Trabectedin 5 CP protocol 5 avelumab 4 atezolizumab 4 Immunoglobulin G 4 Ifosfamide 4 Disulfides 4 Dexamethasone 4 Cyclophosphamide 4 Chemotherapy, Adjuvant 4 1-dodecylpyridoxal 4 trebananib 3 pembrolizumab 3 fluzoparib 3 dostarlimab 3 cediranib 3 apatinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01461850 2020-10-14

SCORPION

Catholic University of the Sacred Heart

Phase 3 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡